Milestone Scientific (NYSE:MLSS – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01), Yahoo Finance reports. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%. The business had revenue of $1.85 million during the quarter.
Milestone Scientific Trading Down 0.8 %
MLSS stock traded down $0.01 during trading on Friday, reaching $0.97. 62,905 shares of the stock were exchanged, compared to its average volume of 109,900. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.19. The company has a market capitalization of $75.10 million, a P/E ratio of -9.73 and a beta of 0.88. The stock has a 50 day simple moving average of $0.83 and a 200-day simple moving average of $0.73.
Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on shares of Milestone Scientific in a report on Wednesday. They issued a “hold” rating for the company.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Articles
- Five stocks we like better than Milestone Scientific
- Find and Profitably Trade Stocks at 52-Week Lows
- This Small Cap Wealth Management Stock Could Provide Big Returns
- NYSE Stocks Give Investors a Variety of Quality Options
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- What is the FTSE 100 index?
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.